Evidence map›Paper›PMID 41480116›Full record

ArticleRevista de salud publica (Bogota, Colombia)2025

[The health-environment perspective as a tool for ecopharmacovigilance].

Diego Mauricio Quijano-Prieto, José Gilberto Orozco-Díaz

Abstract readEnglish Abstract
In one paragraph

Article in Revista de salud publica (Bogota, Colombia), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Diego Mauricio Quijano-PrietoDQ: Ing. Ambiental y Sanitario. M. Sc. Medio Ambiente y Desarrollo. Ph. D.(c) Salud Pública. Investigador. Bogotá, Colombia. dmquijanop@unal.edu.co Universidad Nacional de Colombia Bogotá Colombia dmquijanop@unal.edu.co.
José Gilberto Orozco-DíazJO: MD. Esp. Epidemiología. M. Sc. Ciencias Farmacología. Ph. D. Salud Pública. Universidad Nacional de Colombia. Bogotá, Colombia. jgorozcod@unal.edu.co Universidad Nacional de Colombia Universidad Nacional de Colombia Bogotá Colombia jgorozcod@unal.edu.co.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Environmental pollution by pharmaceutical is an emerging environmental issue and a public health concern. Active pharmaceutical ingredients have been detected in various ecosystems, where they have caused negative impacts, and considering their bioactive properties, they are considered potentially harmful to several species. Ecopharmacovigilance is concerned with the detection, evaluation, understanding, and prevention of adverse effects related to the presence of pharmaceuticals in the environment. This essay analyzes ecopharmacovigilance through a parallel with the book Silent spring, highlighting gaps in knowledge and addressing them with an approach that focuses on social aspects of health-disease-care problems. The present document points out that the current approach to ecopharmacovigilance loses sight of the determining role of social relationships, and focuses on the short-term, the study of isolated factors, and the search for immediate causes. There is a need for a theoretical rethinking of the problem is referred to, where the multiple ecosocial relationships are highlighted. Currently, the society has the possibility of knowing, rethinking, and taking action regarding how humans deal with each other and nature, in relation to health-disease-care issues.

Indexed as

Environmental HealthEnvironmental PollutionPharmacovigilanceHumansEnvironmentenvironmental health (source: MeSH, NLM)environmental pollutionenvironment and public healthpharmaceutical preparationspublic health

Identifiers

PMID41480116
PMCPMC12755206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.